BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15828173)

  • 1. Relation of cell wall lipid content of Serratia marcescens to resistance to antimicrobial agents.
    Winshell EB; Neu HC
    Antimicrob Agents Chemother; 1974 Jul; 6(1):73-5. PubMed ID: 15828173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid content of antibiotic-resistant and -sensitive strains of Serratia marcescens.
    Chang CY; Molar RE; Tsang JC
    Appl Microbiol; 1972 Dec; 24(6):972-6. PubMed ID: 4568257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiogram and lipid analysis of a pigmented strain of Serratia marcescens and its nonpigmented variants.
    Button GL; Miller MA; Tsang JC
    Antimicrob Agents Chemother; 1975 Feb; 7(2):219-22. PubMed ID: 1094951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiograms and lipid contents of pigmented and nonpigmented strains of Serratia marcescens.
    Miller MA; Chang CY; Tsang JC
    Antimicrob Agents Chemother; 1973 Jul; 4(1):66-8. PubMed ID: 4598846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic resistance patterns of clinical isolates of Serratia marcescens.
    Cooksey RC; Bannister ER; Farrar WE
    Antimicrob Agents Chemother; 1975 Apr; 7(4):396-9. PubMed ID: 1096799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of beta-lactamase activity to antimicrobial susceptibility in Serratia marcescens.
    Tsang JC; Sansing GA; Miller MA
    Antimicrob Agents Chemother; 1975 Sep; 8(3):277-81. PubMed ID: 1101819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of some antibiotics on pigmentation in Serratia marcescens.
    Anğ-Küçüker M; Büyükbaba-Boral O; Tolun V; Törümküney D; Susever S; Anğ O
    Zentralbl Bakteriol; 2000 Jan; 289(8):781-5. PubMed ID: 10705609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic susceptibility of nonpigmented Serratia marcescens.
    Thornton GF; Cramer JA
    Antimicrob Agents Chemother (Bethesda); 1970; 10():514-6. PubMed ID: 4939745
    [No Abstract]   [Full Text] [Related]  

  • 9. Natural antibiotic susceptibility of strains of Serratia marcescens and the S. liquefaciens complex: S. liquefaciens sensu stricto, S. proteamaculans and S. grimesii.
    Stock I; Grueger T; Wiedemann B
    Int J Antimicrob Agents; 2003 Jul; 22(1):35-47. PubMed ID: 12842326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad-spectrum antimicrobial activity of secondary metabolites produced by Serratia marcescens strains.
    Clements T; Ndlovu T; Khan W
    Microbiol Res; 2019 Dec; 229():126329. PubMed ID: 31518853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of clinical isolates of Serratia marcescens.
    Alvarez JS; Regueiro B; Garrido MJ
    Antimicrob Agents Chemother; 1979 Oct; 16(4):523-4. PubMed ID: 391150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibmicrobial susceptibility of Serratia marcescens isolated from hospitalized patients in 2003 - 2005].
    Młynarczyk G; Młynarczyk A; Pupek J; Bilewska A; Luczak M
    Med Dosw Mikrobiol; 2007; 59(1):35-42. PubMed ID: 17601029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid profiles in pigmented and non-pigmented strains of S. marcescens.
    Pizzimenti FC; Nostro A; Marino A; Villari A; Verzera A; Trozzi A; Alonzo V
    New Microbiol; 1999 Apr; 22(2):91-8. PubMed ID: 10322607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance of antimicrobial resistance in Serratia marcescens in Mexico.
    González GM; de J Treviño-Rangel R; Campos CL; Villanueva-Lozano H; Bonifaz A; Franco-Cendejas R; López-Jácome LE; Bobadilla Del Valle M; Llaca-Díaz JM; Ayala-Gaytán JJ; Castañón-Olivares LR; Tinoco JC; Andrade A
    New Microbiol; 2020 Jan; 43(1):34-37. PubMed ID: 32334489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipids of antibiotic-resistant and -susceptible members of the Enterobacteriaceae.
    Suling WJ; O'Leary WM
    Can J Microbiol; 1977 Aug; 23(8):1045-51. PubMed ID: 329961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hospital infection due to Serratia marcescens and its sensitivity to antibiotics].
    Filloy L; Serrano D; Borjas E
    Bol Med Hosp Infant Mex; 1980; 37(5):871-7. PubMed ID: 7000092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative susceptibilities of clinical isolates of Serratia marcescens to newer cephalosporins, alone and in combination with various aminoglycosides.
    Markowitz SM; Sibilla DJ
    Antimicrob Agents Chemother; 1980 Nov; 18(5):651-5. PubMed ID: 7004344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serratia marcescens isolated in 2005 from clinical specimens from patients with diminished immunity.
    Młynarczyk A; Młynarczyk G; Pupek J; Bilewska A; Kawecki D; Łuczak M; Gozdowska J; Durlik M; Paczek L; Chmura A; Rowińnski W
    Transplant Proc; 2007 Nov; 39(9):2879-82. PubMed ID: 18022007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibilities and bacteriological characteristics of bovine Pseudomonas aeruginosa and Serratia marcescens isolates from mastitis.
    Ohnishi M; Sawada T; Hirose K; Sato R; Hayashimoto M; Hata E; Yonezawa C; Kato H
    Vet Microbiol; 2011 Dec; 154(1-2):202-7. PubMed ID: 21783330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary tract infections due to Serratia marcescens. I. Antimicrobial susceptibility patterns of clinical isolates of Serratia marcescens (author's transl)].
    Igari J; Kosakai N
    Jpn J Antibiot; 1977 Oct; 30(10):840-6. PubMed ID: 338940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.